Abnormal Pap Test After HPV Vaccination? SaneVax Offers HPV DNA Sequencing Test to Find Out Why

To date, there have been 283 VAERS reports of abnormal Pap tests following HPV vaccination. Gardasil and Cervarix claim to offer protection against the most common HPV viruses associated with cervical cancer. What is wrong with this picture?
By: Norma Erickson, SaneVax Inc.
Sept. 20, 2010 - PRLog -- Both FDA approved HPV vaccines, Gardasil and Cervarix, claim to offer protection from infections by the human papillomavirus genotypes most commonly associated with precancerous lesions and cervical cancer, HPV-16 and HPV-18. The manufacturers are also beginning to claim there is evidence of cross-protection against HPV genotypes 31 and 45. There are at least 283 young women who probably do not believe these statements.

The Vaccine Adverse Event Reporting System (VAERS) is a voluntary system. There are no requirements or legal obligations to report new medical conditions (adverse events) which occur after vaccination. Current estimates say that only 1-10% of the people who actually experience adverse events file reports.

The SaneVax team is concerned that with only 1-10% reporting, there may be as many as 28,300 people who have experienced abnormal Pap tests after HPV vaccination. This is not acceptable collateral damage.

Should you experience an abnormal Pap test after HPV vaccination, you need to know why. You need to know what genotype of HPV, if any, is present in your abnormal cells. If there is a vaccine-relevant genotype present in the abnormal cells, the HPV vaccine did not work as it was expected to.

If there are non-vaccine relevant, high-risk HPV genotypes present in the abnormal cells, the manufacturer of the vaccine may have targeted the wrong genotype of HPV for your geographical area. In that case, the vaccine will not work for anyone who lives near you, and they would need to be informed.

SaneVax has partnered with Dr. Sin Hang Lee and Milford Medical Laboratory to offer a highly sensitive HPV PCR DNA sequencing test to help you find out which scenario is true. This test will accurately determine if there is HPV present and if so, what specific high-risk genotype it is. (visit http://sanevax.org/resources/post-vaccination.shtml for more information.)

There is a third possibility should no high-risk HPV genotype be present in your abnormal cells. Consider the following quote from a publication issued by the National Cancer Institute entitled 'Cervical Cancer Prevention, Health Professional Version,' last modified on 27 August 2010:

"The finding of HPV viral DNA integrated in most cellular genomes of invasive cervical carcinomas supports epidemiologic data linking this agent to cervical cancer, however, direct causation has not ben demonstrated."

Perhaps, after all of the media blitz, awards for creating markets out of thin air, and political pressure to mandate HPV vaccination worldwide, it will be discovered that human papillomavirus does not cause cancer after all.

# # #

SaneVax believes only Safe, Affordable, Necessary & Effective vaccines and vaccination practices should be offered to the public. Our primary goal is to provide scientific information/resources for those concerned about vaccine safety, efficacy and need.
Source:Norma Erickson, SaneVax Inc.
Email:***@gmail.com Email Verified
Tags:Gardasil, Cervarix, Cervical Cancer, Hpv Vaccine, Human Papillomavirus
Industry:Health, Consumer
Location:United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SaneVax, Inc. News
Most Viewed
Daily News

Like PRLog?
Click to Share